 |
 |
 |
||||||||||||||
|
 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
||||
| < 2005 News Listings | ||||||||||||||||
|
NEW YORK, NY February 17, 2005 IntraLinks, the leading provider of secure electronic document exchange service to the life sciences industry, has partnered with ePharmaLearning, a global provider of clinical site activation and online training solutions, to accelerate and improve site qualification, activation, and protocol training. The partnership will help pharmaceutical and medical device companies launch clinical drug trials faster, less expensively, and with a greater chance for success than traditional methods. ePharmaLearning will integrate IntraLinks' 21CFR Part 11-capable secure document exchange service with its Investigator Portal Solution to provide study sites and sponsors with a single hub for clinical trial launches. In addition to the integrated service offering, ePharmaLearning will provide clinical support services to facilitate site qualification, site activation, and training to accelerate and improve study launch. "We have supported the qualification and training of more than 25,000 clinical researchers in over 40 countries over the last four years," said Lance Converse, CEO and Founder of ePharmaLearning. "IntraLinks' secure electronic document exchange technology is a powerful complement to our Investigator Portal. Together, we can provide an end-to-end online solution for study sites and sponsors." Under the partnership, IntraLinks will coordinate its services with ePharmaLearning's SiteActivaterTM, which consolidates the qualification, activation, training, and trial management tools used by study sites. Sites are provided with single, secure, study-specific workspaces for 24x7 access to feasibility surveys, study documents, self-paced eLearning modules, online meetings, and trial management tools. The system time-stamps, tracks and reports on all user activity to support clinical project management and tracking needs. "ePharmaLearning's expertise in site recruitment, qualification and training is the perfect complement to our secure document exchange service," said Richard Jenkins, Vice President of Business Development for IntraLinks. "The combination of IntraLinks' and ePharmaLearning's systems will enable trial sponsors to consolidate tasks, training and document exchange in a single workspace to accelerate drug development timelines." The companies will host a live webinar on March 2, 2005 at 1:00 PM EDT to discuss Investigator Portals and the IntraLinks/ePharmaLearning partnership. To register, go to www.epharmalearning.com/session7.html. About IntraLinks IntraLinks (www.intralinks.com), the leading provider of digital workspaces, connects business communities and accelerates the intelligent flow of information and documents among participants. Through IntraLinks' secure, neutral, online environments, companies are better able to compete globally by accelerating essential business processes, simplifying communication and fostering rapid workflow. IntraLinks is easily accessible anywhere, anytime using a web browser. Since April 1997, more than 200,000 participants representing over 13,000 companies worldwide have used IntraLinks digital workspaces to communicate and collaborate on more than 20,000 projects and transactions. IntraLinks has been rapidly adopted by the financial services and pharmaceutical markets. Over 250 global companies are IntraLinks clients, including AstraZeneca Pharmaceuticals LP, Bank of America, Bear Stearns, Deutsche Bank, Dresdner Kleinwort Wasserstein, Ernst & Young, FDIC, JPMorgan Chase, TD Securities, Thomas Weisel Partners and WestLB. Founded in June 1996, IntraLinks is headquartered in New York with offices in Boston and London. About ePharmaLearning ePharmaLearning (www.epharmalearning.com) is a leading provider of site activation and online training services for the pharmaceutical industry. More than 100 pharmaceutical companies and clinical services providers have used ePharmaLearning's portal and eLearning solutions to activate and train more than 25,000 clinical researchers in over 40 countries. ePharmaLearning is headquartered in Philadelphia with offices in London. For more information call 610-832-9915. |
|
|
Copyright ©2007 Rho Capital Partners, Inc.